Canadian Cancer Society logo

Multiple myeloma

You are here: 

Consolidation therapy for multiple myeloma

Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.

Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).


Helen Storey Thanks to her legacy to ovarian cancer research, Helen Storey is still looking after others.

Read Helen's story

Support from someone who has ‘been there’

Illustration of conversation

The Canadian Cancer Society’s peer support program is a telephone support service that matches cancer patients and their caregivers with specially trained volunteers.

Learn more